Dell Technologies And University Of Limerick Join Forces To Advance Predictive And Diagnostic Cancer Research
Dell News, Tuesday, September 12,2023
Dell Technologies (NYSE:DELL) has joined forces with the University of Limerick's Digital Cancer Research Centre to develop an artificial intelligence (AI) platform and digital twin technology to power predictive and diagnostic research in oncology.
The technology can help clinicians provide more effective cancer care for those with B-cell lymphoma from speeding diagnosis to providing enhanced treatment and improving long-term outcomes for patients in Ireland and worldwide.
Dell created an AI platform for the University that delivers high performance computing power to accelerate oncology and precision medicine research. The platform sits within the Digital Cancer Centre's multicloud ecosystem. It is powered by Dell's latest storage arrays and Dell PowerEdge servers optimised for AI to produce cancer patient digital twins for better diagnostics.